SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending as investors digest an earnings report featuring a massive revenue growth forecast for the upcoming fiscal year and the cancellation of a previously planned share offering. The community is actively debating the company's valuation, with many bulls highlighting record-breaking order backlogs and a potential short squeeze, while skeptics remain focused on long-standing concerns regarding management credibility and legal uncertainties.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors focus on the company's expanding role in the physical AI and automotive software sectors, particularly around the QNX operating system's integration with major hardware partners. Community discussion is heavily focused on anticipation for upcoming management presentations, with bulls pointing to strong design-win pipelines and potential revenue growth while some participants remain skeptical about the timeline for material financial impact.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is facing significant volatility following a weak quarterly report that featured missed revenue expectations and a downward revision to full-year guidance due to lower market prices for antimony. While the community remains divided between frustrated retail investors questioning management's execution and bullish long-term advocates betting on a domestic supply chain shift, the stock remains a focal point for debates regarding geopolitical supply dependencies and potential government support.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending following a significant order from Mears Machine Corporation and positive coverage from Needham, fueling community excitement despite recent volatility. Investors are actively debating the company's long-term potential in the defense and aerospace sectors while monitoring technical support levels and high short interest.

Quantum Corp. engages in the manufacture of computer storage devices. It provides solutions for storing and protecting information in physical, virtual, and cloud environments. Its products and services include Myriad All-Flash File and Object, StorNext File System Unified Surveillance Platform, ActiveScale Object Storage, DXi Backup Appliances, Scalar Tape Storage, CatDV Media Asset Management, and Cloud-Based Analytics. The company was founded by Joel N. Harrison and James M. McCoy in 1980 and is headquartered in Centennial, CO.

Quantum Corp

Quantum Corp (QMCO) is seeing heavy volatility and significant daily gains, fueled largely by traders linking its name to the broader AI infrastructure and quantum computing hype cycle despite the company's focus on data storage. While some investors are betting on a massive short squeeze and long-term turnaround potential, skeptics are warning of a classic pump-and-dump scenario, citing weak fundamentals, frequent share dilution, and the absence of actual quantum computing business.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is trending after reporting positive Phase 3 clinical trial results for its DT120 treatment in major depressive disorder, sparking significant market interest and a rally. The community is actively discussing the stock's clinical prospects, upcoming trial readouts for generalized anxiety disorder, and the broader implications of the company's strong cash position for long-term growth.

T1 Energy, Inc. engages in providing energy solutions focused on solar module and solar cell manufacturing. It focuses on building an integrated U.S. supply chain for solar and batteries. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

T1 Energy Inc. is facing intense selling pressure and high volatility amid community concerns over capital expenditure increases, production timeline delays, and potential shareholder dilution. While some investors view the current dip as a deep-value buying opportunity for long-term solar manufacturing exposure, others are increasingly skeptical due to financing uncertainties and the company's recent preliminary earnings report.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Trulieve Cannabis Corp is currently trending following its historic uplisting to the New York Stock Exchange as the first U.S. cannabis operator, a milestone that has sparked active community debate regarding institutional liquidity versus persistent sector-wide volatility. Investors are closely monitoring the company's future growth strategy in medical-focused markets like Georgia and Texas while speculating on the impact of upcoming DEA administrative hearings on the broader industry's trajectory.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the appointment of former World Bank President Dr. Jim Yong Kim as Vice Chairman, a strategic move the community views as a major signal for global expansion and increased institutional credibility. Investors are actively discussing the stock's potential for a massive breakthrough, specifically focusing on the company's platform, the recent increase in institutional holdings by BlackRock, and the anticipation of further global partnerships and regulatory approvals.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is trending as retail investors rally behind the stock ahead of upcoming quarterly results, fueled by a newly awarded multi-million-dollar defense tender from the Israeli Ministry of Defense. Community discussion remains heavily focused on the potential for a short squeeze, citing high short interest and strong institutional support for the company's autonomous drone technology pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

We're lifting our price target on Cardinal Health after issuing rosy profit guidance

The quarter wasn't totally clean, but strong profitability matters the most...

CAH Q4 Earnings Beat on Pharma Strength, Revenues Miss, Stock Up

Cardinal Health beats fiscal Q4 EPS estimates as profit surges, while revenues miss; fiscal 2027 guidance points to continued earnings growth.

RDNT Q2 Earnings & Sales Beat on Advanced Imaging, Guidance Raised

RadNet tops Q2 estimates as advanced imaging and Digital Health growth accelerate, prompting a higher 2026 Imaging Center outlook.

Existing Home Sales Data in Focus

Small Biz Index, Existing Home Sales & More Earnings

We don't expect much movement either direction until inflation reports begin to hit the tape Wednesday morning.

Cardinal Health Says It Now Exclusively Serves Nearly Half The Cell-And-Gene Therapy Market

CAH stock hits new 52-week high as Cardinal Health beats Q4 earnings, boosts FY27 outlook, and approves a $5B buyback expansion.read more...

US Stocks Mixed; Cardinal Health Shares Jump After Q4 Results

US stocks mixed, Dow up 150 points. Industrials gain 1%, communication services fall 1.1%. Cardinal Health (NYSE: CAH) up 8%. Oil up 0.4%, gold up 0.6%.read more...

Compared to Estimates, Cardinal (CAH) Q4 Earnings: A Look at Key Metrics

Although the revenue and EPS for Cardinal (CAH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Cardinal Health Q4 Profit Climbs, Sees Growth In FY27; Approves $5 Bln Buyback

(RTTNews) - Healthcare services company Cardinal Health, Inc., while reporting significantly higher profit in its fourth quarter on revenue strength, on Tuesday issued fiscal 2027 outlook, expecting higher adjusted earnings...

Cardinal Health (CAH) Q4 Earnings Beat Estimates

Cardinal (CAH) delivered earnings and revenue surprises of +20.25% and -2.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

$CAH Q4 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $1.70 up 68.32% YoY
• Reported revenue of $63.67B up 5.84% YoY
• Cardinal Health provides fiscal year 2027 non-GAAP diluted EPS guidance of 13% to 15% growth, representing a range of $12.40 to $12.60, which is above the company&#39;s long-term EPS guidance.

Stocktwits

Cardinal Health, Inc.

 Q4 '26 Earnings Results & Recap

• Reported GAAP EPS of $1.70 up 68.32% YoY
• Reported revenue of $63.67B up 5.84% YoY
• Cardinal Health provides fiscal year 2027 non-GAAP diluted EPS guidance of 13% to 15% growth, representing a range of $12.40 to $12.60, which is above the company's long-term EPS guidance.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

$CAH Q4 '26 Earnings Results & Recap

• Reported GAAP EPS of $1.70 up 68.32% YoY
• Reported revenue of $63.67B up 5.84% YoY
• Cardinal Health provides fiscal year 2027 non-GAAP diluted EPS guidance of 13% to 15% growth, representing a range of $12.40 to $12.60, which is above the company's long-term EPS guidance.

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

Cardinal Health Opens Distribution Center In Texas, Plans One In California 

Equity

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

CAHCardinal Health, Inc.

Fundamentals

Connect Stocktwits to ChatGPT

Latest CAH News